Nicola E. Wilsher

Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene

S. Sale, Richard D. Verschoyle, David J. Boocock et al. · British Journal of Cancer · 2004 · 259 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy

Iain M. McLay, Frank Halley, John E. Souness et al. · Bioorganic & Medicinal Chemistry · 2001 · 90 citations

Medicine, Medicinal Chemistry, Pharmacology +12

Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP

Gianni Chessari, Ildiko M. Buck, James E. H. Day et al. · Journal of Medicinal Chemistry · 2015 · 86 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Imidazo[4,5-<i>b</i>]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical Development Candidate

Vassilios Bavetsias, Jonathan M. Large, Chongbo Sun et al. · Journal of Medicinal Chemistry · 2010 · 82 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Bioactivation of the phytoestrogen diosmetin by CYP1 cytochromes P450

Vasilis P. Androutsopoulos, Nicola E. Wilsher, Randolph Arroo et al. · Cancer Letters · 2008 · 79 citations

Medicine, Pharmacology, Toxicology +13